|
EP1727822A1
|
|
Novel compounds for modulating cell proliferation
|
|
US2004006777A1
|
|
Human lymphoid protein tyrosine phosphatases
|
|
AU1011602A
|
|
Hybrid compositions for intracellular targeting
|
|
US6800659B2
|
|
Compounds for modulating cell proliferation
|
|
EP1752446A2
|
|
Compounds for modulating cell proliferation
|
|
AU6550800A
|
|
Hepoxilin analogs
|
|
WO0061183A2
|
|
Verotoxin treatment of lymphomas
|
|
CA2367832A1
|
|
Methods and compositions for treating leukemia
|
|
CA2360770A1
|
|
Ras activator nucleic acid molecules - guanine nucleotide releasing factor grf4, polypeptides and methods of use
|
|
CA2335346A1
|
|
Sara proteins
|
|
AU4765499A
|
|
Mammalian fast transcription factor
|
|
US6489446B1
|
|
Self-aligning peptides modeled on human elastin and other fibrous proteins
|
|
US6429293B1
|
|
Sculpin-type antifreeze polypeptides and nucleic acids
|
|
CA2272055A1
|
|
Products and methods for gaucher disease therapy
|
|
CA2326601A1
|
|
Ese genes and proteins
|
|
WO9955728A2
|
|
Ese genes and proteins
|
|
US7118886B1
|
|
Ese genes and proteins
|
|
CA2259830A1
|
|
Ras activator nucleic acid molecules, proteins and methods of use
|
|
CA2318697A1
|
|
Human lymphoid protein tyrosine phosphatases
|
|
CA2255109A1
|
|
Mammalian brainiac genes
|
